← All projects
Medicines

Refoxy FOXO3 longevity medicines

Refoxy Pharmaceuticals

If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.

WHAT IT IS TRYING TO CHANGE

What the project is doing

Refoxy FOXO3 longevity medicines is being developed as part of the wider effort to prevent, delay or repair age-related decline.

What this could do for you

If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.

What has to happen next

The next checkpoint is a reproducible result strong enough to justify human testing.

What could stop it

Results in cells or animals often fail in people, and the route to a safe human treatment can take many years.

WHERE IT STANDS

Current evidence and outlook

Refoxy FOXO3 longevity medicines is being developed as part of the wider effort to prevent, delay or repair age-related decline.

Likely path

Often 8–15 years or more from broad availability.

Why this estimate

Many laboratory and animal projects never reach people.

Record checked: 2026-08-27

ORIGINAL EVIDENCE

Research details and sources

The sources below support the project record. RejuvAccess separately checks whether a practical route is open and worth pursuing.

  1. Official Refoxy company and pipeline
MAKE IT PERSONAL

Could this matter for your situation?

Ask RejuvAccess to check the evidence, access route, cost and next step for you.

Start an access check